Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Damora Therapeutics (DMRA) Capital Expenditures (2021 - 2022)

Damora Therapeutics posted quarterly Capital Expenditures of $41000.0 for Q4 2022, up 1125.0% year-on-year from $3346.9 in Q4 2021, and down 70.29% on a QoQ basis from $138000.0 in Q3 2022.

Damora Therapeutics (DMRA) has 2 years of Capital Expenditures data on file, last reported at $41000.0 in Q4 2022.

  • For the quarter ending Q4 2022, Capital Expenditures rose 1125.0% year-over-year to $41000.0; the trailing twelve-month figure through Dec 2022 stood at $196000.0 (down 12.11% YoY), and the FY2022 full-year result was $196000.0, down 12.11% from the prior year.
  • Capital Expenditures for Q4 2022 stood at $41000.0, down from $138000.0 in the prior quarter.
  • Across five years, Capital Expenditures topped out at $138000.0 in Q3 2022 and bottomed at -$26000.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn -
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 133.40 Mn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 230.60 Mn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 21.83 Mn
10 Damora Therapeutics 853.36 Mn 650.97 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2022 41,000.00
Dec 31, 2022 41,000.00
Sep 30, 2022 138,000.00
Sep 30, 2022 138,000.00
Jun 30, 2022 -26,000.00
Jun 30, 2022 -26,000.00
Mar 31, 2022 43,000.00
Mar 31, 2022 43,000.00
Dec 31, 2021 -4,000.00
Dec 31, 2021 -4,000.00
Sep 30, 2021 47,000.00
Sep 30, 2021 47,000.00
Jun 30, 2021 115,000.00
Jun 30, 2021 115,000.00
Mar 31, 2021 65,000.00
Mar 31, 2021 65,000.00